CanBas Co., Ltd. (TYO:4575)
Japan · Delayed Price · Currency is JPY 564.00
-17.00 (-2.93%)
Jun 3, 2026, 3:30 PM JST
CanBas Market Cap
CanBas has a market cap or net worth of 11.1 billion as of June 2, 2026. Its market cap has decreased by -42.87% in one year.
Market Cap
11.10B
Enterprise Value
9.34B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
564.00
Market Cap Chart
Since September 18, 2009, CanBas's market cap has increased from 8.38B to 11.10B, an increase of 32.46%. That is a compound annual growth rate of 1.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 11.10B | -27.65% |
| Dec 30, 2025 | 15.35B | -10.38% |
| Dec 30, 2024 | 17.13B | 0.65% |
| Dec 29, 2023 | 17.01B | -5.30% |
| Dec 30, 2022 | 17.97B | 974.22% |
| Dec 30, 2021 | 1.67B | -48.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RaQualia Pharma | 13.04B |
| ReproCELL | 12.16B |
| Stella Pharma | 11.88B |
| Immuno-Biological Laboratories | 9.46B |
| Nano Holdings | 9.27B |
| CellSeed | 9.23B |
| Carna Biosciences | 8.65B |
| OncoTherapy Science | 8.06B |